- Home
- Applications
- USA
- drug release delivery
Refine by
Drug Release Delivery Product Applications In Usa
15 applications found
The growing adoption of focused ultrasound to treat tissue non-invasively with thermal or mechanical energy requires robust measurements to ensure safety and ...
ByOnda Corporation based in Sunnyvale, CALIFORNIA (USA)
Our 3D printers are designed to develop research into complex drug formulation and delivery challenges. This includes altering tablet architecture to control release rates, and producing personalized medicines by tailoring therapeutic treatment dosages to better address a patient’s specific needs through combining multiple active components into a single solid form ...
ByRegenhu based in Villaz-St-Pierre, SWITZERLAND
Collagen has been used to coat stents to improve biocompatibility. Collagen coatings may be used as a vehicle for drug ...
ByViscus Biologics LLC based in Cleveland, OHIO (USA)
Researchers have found many uses for MALDI mass spectrometry imaging in the process of drug ...
ByHTX Technologies, LLC based in Chapel Hill,, NORTH CAROLINA (USA)
Aerogen is the only closed-circuit aerosol drug delivery system that mitigates the transmission of patient-generated infectious ...
ByAerogen based in Dangan, IRELAND
Since its inception, Yukon Medical has worked directly with clinicians and users to understand their needs and build products that keep them safe and address the complex challenges associated with current devices. The feedback and input of healthcare workers continues to be at the center of everything we do to inform our iterative, human-centered design process, resulting in products built with clinician needs and patient well-being in ...
ByYukon Medical, LLC based in Durham,, NORTH CAROLINA (USA)
Glaukos is developing multiple micro-invasive, bioerodible, sustained-release drug delivery platforms designed to be used in the treatment of various retinal disease, including age-related macular degeneration (AMD) and diabetic macular ...
ByGlaukos Corporation based in San Clemente, CALIFORNIA (USA)
In this example, the aggregation of magnetic nanoparticles labeled with DiR is monitored in real time. Tumor microvasculature is labeled using ...
ByMauna Kea Technologies based in Paris, FRANCE
Where does viscosity fit when it comes to the Pharmaceutical and Biotechnology Industry?. Protein-based drugs are the fastest growing class of drugs for the treatment of many diseases in humans, ranging from cancer to Alzheimer’s disease. Accurate viscosity values of proteins are essential in understanding behavior, designing delivery systems, and accurately determining particle size/hydrodynamic ...
ByRheoSense Inc based in San Ramo, CALIFORNIA (USA)
Yukon’s Vialok products are behind tens of millions of safe, needle-free medication preparations around the world. We’re trusted by top medical device and pharmaceutical companies, healthcare workers, and even patients who use our vial adapters safely at ...
ByYukon Medical, LLC based in Durham,, NORTH CAROLINA (USA)
Facilitate the construction of human skin equivalents for wound healing research, cosmetic product development or drug delivery ...
ByRegenhu based in Villaz-St-Pierre, SWITZERLAND
Versatile blood research tool: Hemostasis monitoring of newly emerged anticoagulants especially during cardiac surgeries poses more and more challenges to standard diagnostic instrumentations. 3T developers have made pioneering contributions in QCM-D technology for the analysis of health-related whole blood parameters (Oberfrank et al, 2016; Sinn et al, 2011; 2010; Müller et al, 2010). Now the qCell T series provides a sophisticated platform with outstanding potential to face such challenging situations due ...
By3T Analytik GmbH & Co. KG based in Neuhausen ob Eck, GERMANY
Increase clinical translation with Organ-Chips for ADME-Tox assessments. Accurate ADME-Tox profiling of preclinical drug candidates remains a challenge. Preclinical ADME-Tox (Absorption, Distribution, Metabolism, Excretion, and Toxicity) studies are pivotal to predicting human response. However, approximately 30% of drugs fail during human clinical trials due to adverse reactions despite promising preclinical study results, and another 60% fail due to lack of efficacy. As companies broaden the modality toolbox ...
ByEmulate based in Boston, MASSACHUSETTS (USA)
Aptamers are short strands of DNA or RNA with unique secondary and tertiary structures that enable highly selective binding to various types of targets. While aptamers are similar to antibodies in their ability to specifically bind with high affinity, there are some key differences between antibodies and aptamers which have prompted an increase in aptamer development projects. Several hot areas for aptamers, along with specific aptamer advantages, are outlined below. ...
ByBase Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA)
In many therapeutic areas, current treatments involve significant side effects. Combining drug compounds with affinity agents that target specific cell surface receptors can dramatically reduce off-target effects and improve treatment effectiveness. In several studies, aptamer-mediated drug delivery has reduced toxicity and improved drug performance. ...
ByBase Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA)